Title : miR-126-3p contributes to sorafenib resistance in hepatocellular carcinoma via downregulating SPRED1.

Pub. Date : 2021 Jan

PMID : 33553331






6 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 miR-126-3p contributes to sorafenib resistance in hepatocellular carcinoma via downregulating SPRED1. Sorafenib microRNA 1263 Homo sapiens
2 Results: HCC cells with high expression of miR-126-3p exhibited increased resistance to sorafenib. Sorafenib microRNA 1263 Homo sapiens
3 Gain- and loss-of function experiments verified that miR-126-3p induced sorafenib resistance in HCC through downregulating SPRED1. Sorafenib microRNA 1263 Homo sapiens
4 Furthermore, the inhibition of miR-126-3p markedly increased the effectiveness of sorafenib against HCC in vivo. Sorafenib microRNA 1263 Homo sapiens
5 Mechanistically, our results suggested that miR-126-3p promoted sorafenib resistance via targeting SPRED1 and activating the ERK signaling pathway. Sorafenib microRNA 1263 Homo sapiens
6 Conclusions: Our study demonstrates that regulating the miR-126-3p/SPRED1 axis might be a promising strategy for enhancing the antitumor effect of sorafenib in the treatment of HCC. Sorafenib microRNA 1263 Homo sapiens